article thumbnail

Gene Therapy and Pharmacokinetics

Camargo

How and When to Incorporate PK Design into Your Gene Therapy Development Plan. Gene therapy, which was in its infancy around 30 years ago, is now becoming a more prominent treatment method in many therapeutic areas, from personalized therapy to mass vaccinations against COVID-19. Gene Therapy Definition.

article thumbnail

Manufacturing gene therapies, oncolytic viruses, and vaccine candidates: In conversation with ABL

pharmaphorum

Manufacturing gene therapies, oncolytic viruses, and vaccine candidates: In conversation with ABL Mike.Hammerton Thu, 10/08/2023 - 08:00 Bookmark this

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GenScript ProBio and CCS partner for cell and gene therapies development

Pharmaceutical Technology

GenScript ProBio has collaborated with the New York Blood Center Enterprises’ business unit, called Comprehensive Cell Solutions (CCS), to accelerate the development and manufacture of cell and gene therapies. The core objective of the collaboration is to make the therapies affordable and accessible to patients.

article thumbnail

Vaccine and gene therapy focused CDMO secures GMP certification for Belgian site

BioPharma Reporter

Exothera, a CDMO specializing in the industrialization of vaccine and gene therapy processes, reports that it has achieved GMP certification for its facilities in Jumet, Belgium.

article thumbnail

Astellas takes $170m charge as it drops DMD gene therapies

pharmaphorum

Astellas has said it will book a $170 million impairment charge in its fourth quarter results as a result of a decision to halt the development of three gene therapy candidates for Duchenne muscular dystrophy in preclinical development. The post Astellas takes $170m charge as it drops DMD gene therapies appeared first on.

article thumbnail

Catalent to invest $130M in gene therapy plant near Baltimore airport

Bio Pharma Dive

The contract manufacturer is riding a boom in demand for both its gene therapy and vaccine manufacturing services.

article thumbnail

Matica Bio opens new Texas cell and gene therapy facility

BioPharma Reporter

CDMO Matica Bio has opened a new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.